Anuh Pharma stock was down by 3% at Rs. 171. The company reportedly said that the World Health Organisation (WHO) has suspended its products – Pyrazinamide and Sulfadoxine – from prequalified list of active pharmaceutical ingredients (API).
The scrip opened at Rs. 173 and has touched a high and low of Rs. 173 and Rs. 170.2 respectively. So far 7279(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 442.49 crore.
The BSE group 'XC' stock of face value Rs. 5 has touched a 52 week high of Rs. 414.75 on 12-Aug-2015 and a 52 week low of Rs. 159 on 21-Apr-2016. Last one week high and low of the scrip stood at Rs. 179.7 and Rs. 159 respectively.
The promoters holding in the company stood at 70.98 % while Institutions and Non-Institutions held 0 % and 29.02 % respectively.
The stock is currently trading below its 200 DMA.